EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 16:16 ET (22-Jun-2026 20:16 GMT/UTC)

Dana-Farber research helps drive FDA label update for primary CNS lymphoma

Dana-Farber Cancer Institute
Business Announcement

Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system lymphoma, a rare and aggressive lymphoma of the brain and spinal cord. The change is expected to expand access to commercial CAR T-cell therapy for eligible patients with relapsed or refractory disease.

Early diagnosis key to improving childhood cancer survival

University College London
Peer-Reviewed Publication

Childhood cancers, survival rates, early diagnosis, comparing rates by geographical region

Journal: JAMA Network Open
Funder: CHILDREN with CANCER UK, Associazione Italiana per la Ricerca sul Cancro, National Institute for Health Research

First in-human study finds novel immune cell therapy is safe and effective in advanced lymphoma

University of Texas M. D. Anderson Cancer Center
Reports and Proceedings

In a first-in-human study, researchers at The University of Texas MD Anderson Cancer Center observed strong responses and early signs of antitumor activity in patients with difficult-to-treat non-Hodgkin lymphomas who received the novel cell therapy RB-1355. The therapy was effective for those who have relapsed after multiple treatments or no longer responded to standard-of-care options, such as CAR T cell therapy.

Mayo Clinic study finds chemotherapy before surgery improves survival in early-stage pancreatic cancer

Mayo Clinic
Peer-Reviewed Publication

A Mayo Clinic study is providing new insights into how treatment sequence can affect survival in patients with early-stage pancreatic cancer, suggesting that many patients may benefit from receiving chemotherapy before surgery.

Journal: Journal of the National Comprehensive Cancer Network

Let’s get on pancreatic cancer’s nerves

Cold Spring Harbor Laboratory
Peer-Reviewed Publication

Cold Spring Harbor Laboratory postdoc Jeremy Nigri and colleagues in the Tuveson lab have discovered that the nervous system plays an active role in pancreatic cancer development—even before tumor formation. Disrupting interactions between nerves and fibroblasts could lead to new treatments or make standard procedures like chemo and immunotherapy more effective.

Journal: Cancer Discovery
Funder: Defense Health Agency, Thompson Foundation, Pershing Square Foundation, Simons Foundation, Cold Spring Harbor Laboratory, Northwell Health, U.S. Department of Defense, Pancreatic Cancer Action Network, Donaldson Foundation

Simple blood test may help identify colorectal cancer patients at higher risk for recurrence and death

H. Lee Moffitt Cancer Center & Research Institute
Peer-Reviewed Publication

A new study led by researchers at Moffitt Cancer Center found that blood-based DNA markers known as protein epiScores can help predict which colorectal cancer patients face a higher risk of cancer recurrence or death. Results of the study were published in Clinical Epigenetics.

Researchers identified four protein epiScores that were strongly associated with worse outcomes, with patients showing higher levels experiencing a 60% to 70% greater risk of recurrence. One marker, LGALS3BP, was also linked to overall survival, with higher scores associated with an 80% increased risk of death during follow-up.

Journal: Clinical Epigenetics

New study in JNCCN unlocks important information about how to treat recurring prostate cancer

National Comprehensive Cancer Network
Peer-Reviewed Publication

According to new research in JNCCN, information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to predict progression-free survival (PFS) and guide treatment planning in patients with rising prostate-specific antigen (PSA) levels following removal of the prostate.

Journal: Journal of the National Comprehensive Cancer Network

New method boosts control and separation of tiny particles – a promising tool for medical research

University of Oulu, Finland
Peer-Reviewed Publication

In nanoscale particle research, precise control and separation have long been a bottleneck in biotechnology. Researchers at the University of Oulu have now developed a new method that improves particle separation and purification. The promising technique could be applied, for example, in cancer research.

Journal: Analytical Chemistry

Have associations between historical redlining and breast cancer survival changed over time?

Wiley
Peer-Reviewed Publication

Historical redlining, a 1930s–1960s residential segregation policy, has been linked to shorter survival time in people with breast cancer. New research published by Wiley online in CANCER reveals that this association has changed over time, with disparities narrowing until recently.

Journal: Cancer

Discovery of new lymph node architecture reshapes understanding of lymphatic physiology

Tohoku University
Peer-Reviewed Publication

Researchers at Tohoku University discovered an intranodal lympho-venous shunt (a sort of bypass route) that could help us unravel the complicated, intertwined network of our body’s lymphatic system.

Journal: The Journal of Pathology